248 related articles for article (PubMed ID: 21468772)
1. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis and angiogenesis: what do nerves have to do with it?
Zukowska Z
Pharmacol Rep; 2005; 57 Suppl():229-34. PubMed ID: 16415503
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery.
Li L; Lee EW; Ji H; Zukowska Z
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1204-10. PubMed ID: 12689918
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
6. Chronic Administration of Methamphetamine Aggravates Atherosclerotic Vulnerable Plaques in Apolipoprotein E Knockout Mice Fed with a High-cholesterol Diet.
Cui X; Gao B; Yu Y; Gu Y; Hu L
Curr Mol Med; 2024; 24(4):495-504. PubMed ID: 36944618
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Zukowska Z; Pons J; Lee EW; Li L
Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
[TBL] [Abstract][Full Text] [Related]
8. Physical exercise inhibits atherosclerosis development by regulating the expression of neuropeptide Y in apolipoprotein E-deficient mice.
Wu WQ; Peng S; Wan XQ; Lin S; Li LY; Song ZY
Life Sci; 2019 Nov; 237():116896. PubMed ID: 31605707
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
11. Stress, NPY and vascular remodeling: Implications for stress-related diseases.
Kuo LE; Abe K; Zukowska Z
Peptides; 2007 Feb; 28(2):435-40. PubMed ID: 17241699
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of methamphetamine promotes atherosclerosis formation in ApoE-/- knockout mice fed normal diet.
Gao B; Li L; Zhu P; Zhang M; Hou L; Sun Y; Liu X; Peng X; Gu Y
Atherosclerosis; 2015 Nov; 243(1):268-77. PubMed ID: 26409626
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy.
Yoon HZ; Yan Y; Geng Y; Higgins RD
Clin Exp Ophthalmol; 2002 Dec; 30(6):424-9. PubMed ID: 12427234
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
[TBL] [Abstract][Full Text] [Related]
16. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice.
Lee EW; Grant DS; Movafagh S; Zukowska Z
Peptides; 2003 Jan; 24(1):99-106. PubMed ID: 12576090
[TBL] [Abstract][Full Text] [Related]
17. Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation.
Lagraauw HM; Westra MM; Bot M; Wezel A; van Santbrink PJ; Pasterkamp G; Biessen EA; Kuiper J; Bot I
Atherosclerosis; 2014 Jul; 235(1):196-203. PubMed ID: 24858338
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
[TBL] [Abstract][Full Text] [Related]
19. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors.
Li L; Jönsson-Rylander AC; Abe K; Zukowska Z
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2075-80. PubMed ID: 16051880
[TBL] [Abstract][Full Text] [Related]
20. Platelet neuropeptide Y is critical for ischemic revascularization in mice.
Tilan JU; Everhart LM; Abe K; Kuo-Bonde L; Chalothorn D; Kitlinska J; Burnett MS; Epstein SE; Faber JE; Zukowska Z
FASEB J; 2013 Jun; 27(6):2244-55. PubMed ID: 23457218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
